Rhubarb extract prevents hepatic inflammation induced by acute alcohol intake, an effect related to the modulation of the gut microbiota

Molecular Nutrition and Food Research

Volumn 61, Issue 1, 2017, Pages

  Neyrinck, Audrey M ^a   Etxeberria, Usune ^a,b   Taminiau, Bernard ^c   Daube, Georges ^c   Van Hul, Matthias ^a,d   Everard, Amandine ^a,d   Cani, Patrice D ^a,d   Bindels, Laure B ^a   Delzenne, Nathalie M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF NAVARRA   (Spain)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d Louvain Drug Research Institute   (Belgium)

Author keywords

Akkermansia muciniphila; Alcoholic liver disease; Antimicrobial peptides; Gut barrier; Microbiota; Parabacteroides goldsteinii; Steatosis

Indexed keywords

PLANT EXTRACT; RIBOSOME DNA;

ANIMAL; BINGE DRINKING; C57BL MOUSE; CHEMISTRY; COMPLICATION; DRUG EFFECTS; GENETICS; HEPATITIS, ALCOHOLIC; INTESTINE; INTESTINE FLORA; MALE; METABOLISM; OXIDATIVE STRESS; RHEUM;

ANIMALS; BINGE DRINKING; DNA, RIBOSOMAL; GASTROINTESTINAL MICROBIOME; HEPATITIS, ALCOHOLIC; INTESTINES; MALE; MICE, INBRED C57BL; OXIDATIVE STRESS; PLANT EXTRACTS; RHEUM;

EID: 84971552294     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201500899     Document Type: Article

References (56)

1. Shukla, S. D., Pruett, S. B., Szabo, G., Arteel, G. E., Binge ethanol and liver: new molecular developments. Alcohol Clin. Exp. Res. 2013, 37, 550–557.
2. Dugum, M., McCullough, A., Diagnosis and management of alcoholic liver disease. J. Clin. Transl. Hepatol. 2015, 3, 109–116.
3. Mantena, S. K., King, A. L., Andringa, K. K., Eccleston, H. B. et al., Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic. Biol. Med. 2008, 44, 1259–1272.
4. Donohue, T. M. Jr., Osna, N. A., Trambly, C. S., Whitaker, N. P. et al., Early growth response-1 contributes to steatosis development after acute ethanol administration. Alcohol Clin. Exp. Res. 2012, 36, 759–767.
5. Donohue, T. M. Jr., Alcohol-induced steatosis in liver cells. World J. Gastroenterol. 2007, 13, 4974–4978.
6. Stewart, S., Jones, D., Day, C. P., Alcoholic liver disease: new insights into mechanisms and preventative strategies. Trends Mol. Med. 2001, 7, 408–413.
7. Marmier, S., Dentin, R., Daujat-Chavanieu, M., Guillou, H. et al., Novel role for carbohydrate responsive element binding protein in the control of ethanol metabolism and susceptibility to binge drinking. Hepatology 2015, 62, 1086–1100.
8. Vassallo, G., Mirijello, A., Ferrulli, A., Antonelli, M. et al., Review article: alcohol and gut microbiota - the possible role of gut microbiota modulation in the treatment of alcoholic liver disease. Aliment. Pharmacol. Ther. 2015, 41, 917–927.
9. Massey, V. L., Arteel, G. E., Acute alcohol-induced liver injury. Front. Physiol. 2012, 3, 193.
10. Canesso, M. C. C., Lacerda N. L., Ferreira C. M., Gonçalves J. L. et al., Comparing the effects of acute alcohol consumption in germ-free and conventional mice: the role of the gut microbiota. BMC Microbiol. 2014, 14, 240.
11. Hammer, A. M., Khan, O. M., Morris, N. L., Li, X. et al., The effects of alcohol intoxication and burn injury on the expression of claudins and mucins in the small and large intestines. Shock 2016, 45, 73–81.
12. Leclercq, S., Matamoros, S., Cani, P. D., Neyrinck, A. M. et al., Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc. Natl. Acad. Sci. U S A 2014, 111, E4485–E4493.
13. Gao, B., Bataller, R., Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011, 141, 1572–1585.
14. Pan, M. H., Lai, C. S., Ho, C. T., Anti-inflammatory activity of natural dietary flavonoids. Food Funct. 2010, 1, 15–31.
15. Yao, L. H., Jiang, Y. M., Shi, J., Tomas-Barberan, F. A. et al., Flavonoids in food and their health benefits. Plant Foods Hum. Nutr. 2004, 59, 113–122.
16. Ding, R. B., Tian, K., Huang, L. L., He, C. W. et al., Herbal medicines for the prevention of alcoholic liver disease: a review. J. Ethnopharmacol. 2012, 144, 457–465.
17. Huang, Q., Lu, G., Shen, H. M., Chung, M. C. et al., Anti-cancer properties of anthraquinones from rhubarb. Med. Res. Rev. 2007, 27, 609–630.
18. Zhao, Y. L., Wang, J. B., Zhou, G. D., Shan, L. M. et al., Investigations of free anthraquinones from rhubarb against alpha-naphthylisothiocyanate-induced cholestatic liver injury in rats. Basic Clin. Pharmacol. Toxicol. 2009, 104, 463–469.
19. Bindels, L. B., Neyrinck, A. M., Salazar, N., Taminiau, B. et al., Non digestible oligosaccharides modulate the gut microbiota to control the development of leukemia and associated cachexia in mice. PLoS One 2015, 10, e0131009.
20. Neyrinck, A. M., Possemiers, S., Verstraete, W., De, B. F. et al., Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice. J. Nutr. Biochem. 2012, 23, 51–59.
21. Esterbauer, H., Cheeseman, K. H., Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990, 186, 407–421.
22. Szabados, E., Fischer, G. M., Toth, K., Csete, B. et al., Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat. Free Radic. Biol. Med. 1999, 26, 309–317.
23. De, C. C., Oevermann, A., Burgener, I. A., Doherr, M. G. et al., Gastrointestinal tract mucosal histomorphometry and epithelial cell proliferation and apoptosis in neonatal and adult dogs. J. Anim. Sci. 2010, 88, 2255–2264.
24. Kitazawa, H., Nishihara, T., Nambu, T., Nishizawa, H. et al., Intectin, a novel small intestine-specific glycosylphosphatidylinositol-anchored protein, accelerates apoptosis of intestinal epithelial cells. J. Biol. Chem. 2004, 279, 42867–42874.
25. Cliffe, L. J., Humphreys, N. E., Lane, T. E., Potten, C. S. et al., Accelerated intestinal epithelial cell turnover: a new mechanism of parasite expulsion. Science 2005, 308, 1463–1465.
26. Szabo, G., Gut-liver axis in alcoholic liver disease. Gastroenterology 2015, 148, 30–36.
27. Rao, R. K., Acetaldehyde-induced barrier disruption and paracellular permeability in Caco-2 cell monolayer. Methods Mol. Biol. 2008, 447, 171–183.
28. Wang, Y., Liu, Y., Sidhu, A., Ma, Z. et al., Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury. Am. J. Physiol Gastrointest. Liver Physiol. 2012, 303, G32–G41.
29. Turner, J. R., Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 2009, 9, 799–809.
30. Schnabl, B., Brenner, D. A., Interactions between the intestinal microbiome and liver diseases. Gastroenterology 2014, 146, 1513–1524.
31. Adachi, Y., Moore, L. E., Bradford, B. U., Gao, W. et al., Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 1995, 108, 218–224.
32. Ferrier, L., Berard, F., Debrauwer, L., Chabo, C. et al., Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents. Am. J. Pathol. 2006, 168, 1148–1154.
33. Roberfroid, M., Gibson, G. R., Hoyles, L., McCartney, A. L. et al., Prebiotic effects: metabolic and health benefits. Br. J. Nutr. 2010, 104 (Suppl 2), S1–63.
34. Duenas, M., Munoz-Gonzalez, I., Cueva, C., Jimenez-Giron, A. et al., A survey of modulation of gut microbiota by dietary polyphenols. Biomed. Res. Int. 2015, 2015, 850902.
35. Anhe, F. F., Varin, T. V., Le, B. M., Desjardins, Y. et al., Gut microbiota dysbiosis in obesity-linked metabolic diseases and prebiotic potential of polyphenol-rich extracts. Curr. Obes. Rep. 2015, 4, 389–400.
36. Yan, A. W., Fouts, D. E., Brandl, J., Starkel, P. et al., Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 2011, 53, 96–105.
37. Gallo, R. L., Hooper, L. V., Epithelial antimicrobial defence of the skin and intestine. Nat. Rev. Immunol. 2012, 12, 503–516.
38. Everard, A., Lazarevic, V., Gaia, N., Johansson, M. et al., Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J. 2014, 8, 2116–2130.
39. Vereecke, L., Beyaert, R., van, L. G., Enterocyte death and intestinal barrier maintenance in homeostasis and disease. Trends Mol. Med. 2011, 17, 584–593.
40. Khan, I. A., Nasiruddin, M., Haque, S. F., Khan, R. A., Evaluation of Rhubarb Supplementation in Stages 3 and 4 of Chronic Kidney Disease: A Randomized Clinical Trial. Int. J. Chronic Dis. 2014, 2014, 789340.
41. Hasper, I., Ventskovskiy, B. M., Rettenberger, R., Heger, P. W. et al., Long-term efficacy and safety of the special extract ERr 731 of Rheum rhaponticum in perimenopausal women with menopausal symptoms. Menopause 2009, 16, 117–131.
42. Ding, Y., Zhao, L., Mei, H., Zhang, S. L. et al., Exploration of Emodin to treat alpha-naphthylisothiocyanate-induced cholestatic hepatitis via anti-inflammatory pathway. Eur. J. Pharmacol. 2008, 590, 377–386.
43. Arosio, B., Gagliano, N., Fusaro, L. M., Parmeggiani, L. et al., Aloe-emodin quinone pretreatment reduces acute liver injury induced by carbon tetrachloride. Pharmacol. Toxicol. 2000, 87, 229–233.
44. Jin, H., Sakaida, I., Tsuchiya, M., Okita, K., Herbal medicine Rhei rhizome prevents liver fibrosis in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. Life Sci. 2005, 76, 2805–2816.
45. Wang, J. B., Zhao, H. P., Zhao, Y. L., Jin, C. et al., Hepatotoxicity or hepatoprotection? Pattern recognition for the paradoxical effect of the Chinese herb Rheum palmatum L. in treating rat liver injury. PLoS One 2011, 6, e24498.
46. Wang, J., Zhao, Y., Xiao, X., Li, H. et al., Assessment of the renal protection and hepatotoxicity of rhubarb extract in rats. J. Ethnopharmacol. 2009, 124, 18–25.
47. Dryden, G. W. Jr., Deaciuc, I., Arteel, G., McClain, C. J., Clinical implications of oxidative stress and antioxidant therapy. Curr. Gastroenterol. Rep. 2005, 7, 308–316.
48. Morgan, K., French, S. W., Morgan, T. R., Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage. Hepatology 2002, 36, 122–134.
49. Kono, H., Rusyn, I., Yin, M., Gabele, E. et al., NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J. Clin. Invest 2000, 106, 867–872.
50. Ceccarelli, S., Nobili, V., Alisi, A., Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease. World J. Gastroenterol. 2014, 20, 16443–16451.
51. Uesugi, T., Froh, M., Arteel, G. E., Bradford, B. U. et al., Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 2001, 34, 101–108.
52. Beutler, B., Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases. Immunol. Rev. 2009, 227, 248–263.
53. Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P. et al., Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. U S A 2013, 110, 9066–9071.
54. Everard, A., Lazarevic, V., Derrien, M., Girard, M. et al., Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 2011, 60, 2775–2786.
55. Chang, C. J., Lin, C. S., Lu, C. C., Martel, J. et al., Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat. Commun. 2015, 6, 7489.
56. Delzenne, N. M., Bindels, L. B., Gut microbiota: Ganoderma lucidum, a new prebiotic agent to treat obesity? Nat. Rev. Gastroenterol. Hepatol. 2015, 12, 553–554.